Tyme Technologies, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 22 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-11-22: Reporting owner Biehl James; Form 4; Security Director Stock Option - right to buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-11-22: Reporting owner Carberry David; Form 4; Security Director Stock Option - right to buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-11-22: Reporting owner Sturman Paul L; Form 4; Security Director Stock Option - right to buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-11-22: Reporting owner Taylor Ben R; Form 4; Security Employee Stock Option - right to buy; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-11-22 | Biehl James Director | 4 | Director Stock Option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,270 22,270 owned after | $4.10 exercise price | 2017-11-27 | |
| 2017-11-22 | Carberry David Director | 4 | Director Stock Option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,270 22,270 owned after | $4.10 exercise price | 2017-11-27 | |
| 2017-11-22 | Sturman Paul L Director | 4 | Director Stock Option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,880 14,880 owned after | $4.10 exercise price | 2017-11-27 | |
| 2017-11-22 | Taylor Ben R Officer (President, CFO) | 4 | Employee Stock Option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $4.10 exercise price | 2017-11-27 | |
| 2017-11-22 | Taylor Ben R Officer (President, CFO) | 4 | Employee Stock Option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +129,957 129,957 owned after | $4.10 exercise price | 2017-11-27 | |
| 2017-11-22 | TYSON TIMOTHY Director | 4 | Director Stock Option - right to buy Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,958 50,958 owned after | $4.10 exercise price | 2017-11-27 | |
| 2017-11-17 holding as of filing | Eckard Jonathan Director | 3 | Director Stock Option - right to buy Derivative · Direct | Holding | $4.31 exercise price | 2017-11-17 | ||
| 2017-07-27 holding as of filing | Carberry David Director | 3 | Director Stock Option - right to buy Derivative · Direct | Holding | $2.95 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Sturman Paul L Director | 3 | Director Stock Option - right to buy Derivative · Direct | Holding | $2.90 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Biehl James Director | 3 | Director Stock Option - right to buy Derivative · Direct | Holding | $2.95 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Biehl James Director | 3 | Call Option - right to buy Derivative · Direct | Holding | $2.00 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Biehl James Director | 3 | Call Option - right to buy Derivative · Direct | Holding | $2.00 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Hoffman Steve Director, Officer (CEO and Chief Science Officer), 10% Owner | 3 | Employee Stock Option - right to buy Derivative · Direct | Holding | $8.75 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Hoffman Steve Director, Officer (CEO and Chief Science Officer), 10% Owner | 3 | Option - obligation to sell Derivative · Direct | Holding | $2.00 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Taylor Ben R Officer (President and CFO) | 3 | Employee Stock Option - right to buy Derivative · Direct | Holding | $2.95 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Demurjian Michael Director, Officer (Chief Operating Officer), 10% Owner | 3 | Employee Stock Option - right to buy Derivative · Direct | Holding | $8.75 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Demurjian Michael Director, Officer (Chief Operating Officer), 10% Owner | 3 | Option - obligation to sell Derivative · Direct | Holding | $2.00 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Del Priore Giuseppe Officer (Chief Medical Officer) | 3 | Employee Stock Option - right to buy Derivative · Direct | Holding | $8.75 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Del Priore Giuseppe Officer (Chief Medical Officer) | 3 | Employee Stock Option - right to buy Derivative · Direct | Holding | $3.75 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Del Priore Giuseppe Officer (Chief Medical Officer) | 3 | Employee Stock Option - right to buy Derivative · Direct | Holding | $2.75 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | TYSON TIMOTHY Director | 3 | Director Stock Option - right to buy Derivative · Direct | Holding | $8.75 exercise price | 2017-07-27 | ||
| 2017-07-27 holding as of filing | Sokol Gerald H Director | 3 | Director Stock Option - right to buy Derivative · Direct | Holding | $8.75 exercise price | 2017-07-27 |